Background
Methods
Literature search
Literature selection and data extraction
Statistical analysis
Results
HCV GT distribution
A profile of HCV GT data
Region | Province | Genotyping method | Amplified fragment |
---|---|---|---|
Central China1* | Hunan, Hubei, Henan | Nested-PCR and sequence analysis, PCR-RDB, GT-specific primers PCR method, gene chip assay | Core and E1, NS5B and/or Core-E1, NS5B, 5’UTR, core |
East China2* | Shandong, Jiangsu, Anhui, Jiangxi, Fujian, Shanghai, Zhejiang | Nested-PCR and sequence analysis, RFLP, GT-specific primers PCR method, gene chip assay, Genotyping detection kit (DNA sequence assay), PCR-RDB, Micro plate nucleic acid hybridization-ELISA technique, LiPA | 5’-UTR, core, NS5B and/or core-E1, 5’-UTR and/or NS5B, NS5B and C/E2, core and NS5B and 5’-UTR, E2, NS5B and E2 |
South China3* | Guangdong, Guangxi, Hainan | Nested-PCR and sequence analysis, GT-specific primers PCR method, gene chip assay, PCR – RDB, LiPA | NS5B and E1, core and NS5B, E1, NS5B, 5’-UTR and NS5B |
North China4* | Beijing, Shanxi, Tianjin, Hebei, IM | RFLP, Nested-PCR and sequence analysis, GT-specific primers PCR method, gene chip assay, PCR fluorescent probe method | Core, C/E1, 5’-UTR |
Southwest5* | Sichuan, Yunnan, Chongqing, Guizhou | gene chip assay, RFLP, Nested-PCR and sequence analysis, PCR-RDB, Type specific probe hybridization method | 5’-UTR, 5’UTR-core and E1-E2 and NS5B, 5’NCR-C and NS5B, core/E1 and NS5B, E1/E2 and NS5B, 5’-UTR and Core, core and E1, core, C/E1, NS5B |
Northwest6* | Gansu, Sha anxi, Xinjiang | Nested-PCR and sequence analysis, RFLP, PCR-RDB,GT-specific primers PCR method,LiPA, restriction endonuclease cleaving method | E1 and NS5B, 5’NCR, NS5B |
Northeast7* | Liaoning, Heilongjiang, Jilin | RFLP, Nested-PCR and sequence analysis, PCR – RDB, type-specific primers PCR method, gene chip assay | NS5, Core, 5’UTR, C and E1 and NS5 |
HCV GT distribution among clinical cases in mainland China
Study location | Province | The dominated two GTs in each province | The other distributed GTs |
---|---|---|---|
East China | Shandong | 1b 67.74% (95% CI: 60.94–74.53%) | 6a,1a,3a,3b |
2a 27.57% (95% CI: 22.76–32.38%) | |||
Jiangsu | 1b 75.77% (95% CI: 72.47–79.07%) | 2i, 3b, 3a, 1a, 6a, 2b, 6 h, 1c, 6b | |
2a 11.01% (95% CI: 8.77–13.25%) | |||
Anhui | 1b 66.45% (95% CI: 47.57–85.32%) | 3b, 3a, 6 k, 1a, 2b | |
2a 16.52% (95% CI: 8.77–24.28%) | |||
Zhejiang | 1b 67.95% (95% CI: 56.70–79.20%) | 3b, 3a, 6a, 1a | |
2a 11.06% (95% CI: 9.06–13.05%) | |||
Jiangxi | 1b 70.28% (95% CI: 52.38–88.19%) | 2a, 2b, 3a,3b | |
6a 21.82% (95% CI: 10.90–32.73%) | |||
Fujian | 1b 66.17% (95% CI: 33.93–98.4%) | 3b, 6a, 3a, 2b,6b | |
2a 17.42% (95% CI: 11.45–23.39%) | |||
Shanghai | 1b 80.14% (95% CI: 69.64–90.63%) | 3a,3b,1a,6n,6a | |
2a 13.28% (95% CI: 8.22–18.35%) | |||
South China | Guangdong | 1b 63.91% (95% CI: 58.48–69.34% | 2a, 3b, 3a, 1a, 6e, 6n, 4, 2b, 5a, |
6a 17.32% (95% CI: 14.44–20.21%) | 1c, 2f | ||
Guangxi | 1b 56.46% (95% CI: 50.73–62.20%) | 3b, 1a, 2a, 3a, 6d | |
6a 12.88% (95% CI: 9.00–16.75%) | |||
Hainan | 1b 62.50% (95% CI: 51.32–73.68%) | 3a | |
2a 29.17% (95% CI: 18.67–39.67%) | |||
North China | Beijing | 1b 70.41% (95% CI: 65.95–74.87%) | 1a,2b,3a |
2a 22.15% (95% CI: 17.22–27.08%) | |||
Hebei | 1b 46.56% (95% CI: 40.69–52.44%) | 1a,2b,3a | |
2a 36.69% (95% CI: 30.05–43.34%) | |||
Shanxi | 1b 67.22% (95% CI: 57.44–77.00%) | 1a,3a | |
2a 13.51% (95% CI: 6.37–20.65%) | |||
Tianjin | 1b 84.21% (95% CI: 72.62%-95.8%) | ||
2a 13.16% (95% CI: 2.41–23.91%) | |||
Inner Mongolia | 1b 63.27% (95% CI: 38.34–88.20%) | 3a,1a | |
2a 33.33% (95% CI: 11.97–54.70%) | |||
Central China | Hunan | 1b 41.04% (95% CI: 33.71–48.37%) | 3b,2a,3a,5a |
6a 18.50% (95% CI: 12.71–24.28%) | |||
Hubei | 1b 74.08% (95% CI: 66.69–81.47%) | 3b, 6a, 3a, 1a,2b,6b | |
2a 12.68% (95% CI: 8.91–16.46%) | |||
Henan | 1b 78.57% (95% CI: 62.47–94.66%) | 6a,3a,3b,1a | |
2a 14.26% (95% CI: 5.71–22.8%) | |||
Southwest | Sichuan | 1b 78.84% (95% CI: 73.01–84.66%) | 2a |
3b 8.47% (95% CI: 4.50–12.43%) | |||
Yunnan | 3b 49.50% (95% CI: 38.01–60.98%) | 3a, 2a, 6n, 6a | |
1b 20.52% (95% CI: 16.31–24.73%) | |||
Tibet | 1b 49.63% (95% CI: 41.27–58.0%) | 1a | |
2a 16.38% (95% CI: −5.30–38.06%) | |||
Guizhou | 1b 35.22% (95% CI: 30.92–39.52%) | 6a, 3a, 2a, 1a, 2b, 6d | |
3b 21.93% (95% CI: 18.22–25.65%) | |||
Chongqing | 1b 32.21% (95% CI: 25.04–39.38%) | 2a, 6a, 3a, 1a, 6b, 2b,3 k | |
3b 21.86% (95% CI: 7.99–35.73%) | |||
Northwest | Shaanxi | 1b 50.74% (95% CI: 42.35–59.14%) | 6a, 3a, 3b |
2a 40.39% (95% CI: 32.15–48.62%) | |||
Gansu | 1b 56.07% (95% CI: 49.91–62.23%) | 1c, 1a, 2c, 3a, 2b, 3b | |
2a 26.74% (95% CI: 16.44–37.03%) | |||
Xinjiang | 1b 62.71% (95% CI: 60.10–65.33%) | 1a, 3a, 2b, 3b, 4, 6a | |
2a 18.10% (95% CI: 11.99–24.2%) | |||
Qinghai | 1b 49.08% (95% CI: 30.01–68.16%) | 3b, 3a | |
2a 33.8% (95% CI: 26.84–40.76%) | |||
Northeast | Heilongjiang | 1b 48.46% (95% CI: 41.29–55.62%) | 2c, 2b, 1a, 3a |
2a 37.73% (95% CI: 28.82–46.65%) | |||
Liaoning | 1b 44.87% (95% CI: 24.30–65.44%) | 1a, 2i, 3a, 1c, 2b, 3b, 3 k, 2 k | |
2a 34.37% (95% CI: 11.24–57.50%) | |||
Jilin | 1b 56.44% (95% CI: 50.51–62.38%) | 2b, 1a,3a | |
2a 31.96% (95% CI: 19.42–44.50%) |
Region | Subtype | Year | Proportion |
P
|
---|---|---|---|---|
South China | ||||
1b | Before 2005 | 63.35% (159/251) | <0.05 | |
2005–2010 | 63.09% (400/634) | |||
After 2010 | 55.00% (363/660) | |||
2a | Before 2005 | 14.34% (36/251) | <0.05 | |
2005–2010 | 8.83% (56/634) | |||
After 2010 | 9.39% (62/660) | |||
3 | Before 2005 | 6.28% (12/191) | <0.05 | |
2005–2010 | 3.55% (45/1268) | |||
After 2010 | 8.08% (91/1126) | |||
Southwest | 1b | Before 2005 | 36.99% (54/146) | <0.05 |
2005–2010 | 18.98% (41/216) | |||
After 2010 | 35.23% (167/474) | |||
2a | Before 2005 | 21.92% (32/146) | <0.05 | |
2005–2010 | 6.48% (14/216) | |||
After 2010 | 3.04% (11/362) | |||
3 | Before 2005 | 11.21% (25/223) | <0.05 | |
2005–2010 | 31.71% (137/432) | |||
After 2010 | 18.88% (179/948) |
HCV GT characteristics of co-infection in China
HCV GTs and different population demographics
HCV GTs and viral loads
Subtypes | HCV RNA levels (lg copies/ml) | |
---|---|---|
<106
| ≥106
| |
1b | 937 | |
2a | 208 | 41 |
3a | 62 | 16 |
3b | 27 | 66 |
6a | 177 |
HCV GTs and severity of hepatitis
Subtypes | Degree of liver disease | ||
---|---|---|---|
chronic hepatitis | liver cirrhosis | hepatocarcinoma | |
1aa
| 8 | 1 | 1 |
1b | 395 | 165 | 46 |
2a | 228 | 41 | 13 |
3a | 23 | 5 | |
3b | 35 | 2 |